Medication info

Septanest Injection 1/100,000

Prescription medicationInjection
Ingredient · strength
Articaine Hydrochloride›40mg / 1mLEpinephrine Tartrate›0.018mg / 1mL
Manufacturer / importer
Shinwon Dental Co.,LTD.
Appearance
A cartridge-type ampoule filled with a colorless, transparent liquid
Packaging
1.7㎖ × 50 cartridges
Approval status
Active

MFDS item code 200308019 · Approved 2003.02.12 · Insurance code 658300020

Summary

Main use
Pain control through dental local anesthesia (infiltration and nerve block)
Who receives it
Adults · Children
Adult administration
Administer by local or regional injection into the oral mucosa. Perform an aspiration test to ensure that the drug is not injected into a blood vessel. The injection rate must not exceed 1mL per minute. 1. Adults The recommended doses for routine procedures are shown in Table 1. The actual dose used is determined according to the type and extent of the surgical procedure, depth of anesthesia, degree of muscle relaxation, and patient's condition. In all cases, administer the minimum dose needed to achieve the desired result. Do not exceed 7mg of articaine hydrochloride per kg of body weight. The maximum dose for healthy adults weighing 70kg or more is 500mg. [Table 1] The recommended doses are for guidance only. Procedure Dose (mL) Total dose of articaine hydrochloride (mg) Infiltration 0.5~2.5 20~100 Nerve block 0.5~3.4 20~136 Oral surgery 1.0~5.1 40~204
Child administration
Age 4 years and older: Determine the dose according to the child's age, body weight, and type of procedure. Use the minimum dose needed for effective dental anesthesia. Children 4 years of age (or weighing 20 kg or more) and older: The maximum dose of articaine hydrochloride must not exceed 5 mg per kg of body weight.

Ingredients

Importer
Shinwon Dental Co.,LTD.

Efficacy & effects

Pain control through dental local anesthesia (infiltration and nerve block)

View approved original text

Local anesthesia, infiltration anesthesia, and conductive anesthesia during dental procedures are methods used to temporarily block the nerve function in a specific area so that the patient does not experience pain. Local anesthesia is applied to a small area to reduce pain, infiltration anesthesia is injected directly into the tissue to block sensation in the surrounding area, and conductive anesthesia administers the drug around nerves to block sensation in a wide area. These anesthesia methods safely and effectively minimize discomfort during dental procedures, allowing patients to receive treatment comfortably and play an important role in pain management. It is primarily used for pain relief during dental treatment.

How it is given

Adult administration

Administer by local or regional injection into the oral mucosa. Perform an aspiration test to ensure that the drug is not injected into a blood vessel. The injection rate must not exceed 1mL per minute. 1. Adults The recommended doses for routine procedures are shown in Table 1. The actual dose used is determined according to the type and extent of the surgical procedure, depth of anesthesia, degree of muscle relaxation, and patient's condition. In all cases, administer the minimum dose needed to achieve the desired result. Do not exceed 7mg of articaine hydrochloride per kg of body weight. The maximum dose for healthy adults weighing 70kg or more is 500mg. [Table 1] The recommended doses are for guidance only. Procedure Dose (mL) Total dose of articaine hydrochloride (mg) Infiltration 0.5~2.5 20~100 Nerve block 0.5~3.4 20~136 Oral surgery 1.0~5.1 40~204

Child administration

Age 4 years and older: Determine the dose according to the child's age, body weight, and type of procedure. Use the minimum dose needed for effective dental anesthesia. Children 4 years of age (or weighing 20 kg or more) and older: The maximum dose of articaine hydrochloride must not exceed 5 mg per kg of body weight.

Precautions

This medication can lead to severe seizures or central nervous system and cardiac respiratory failure if accidentally injected into a blood vessel, causing sudden systemic exposure to epinephrine and articaine, potentially resulting in loss of consciousness or, in severe cases, respiratory and circulatory arrest. Therefore, an aspiration test must be conducted before injection to ensure that the needle does not enter a blood vessel. Patients with hypertension or diabetes should be cautious as the use of this drug may increase the risk of local tissue necrosis. This drug should not be administered to specific patients, including those allergic to this drug or amide local anesthetics, patients with cardiac conduction disturbances not compensated by a pacemaker, patients with intermittent acute porphyria, uncontrolled epilepsy, children under 4 years old, those who are to be co-administered with medications like guanethidine, patients with cardiovascular diseases, hyperthyroidism, myasthenia gravis, those using monoamine oxidase inhibitors or tricyclic antidepressants, and patients who may need general anesthesia, among others. Patients on antiplatelet or anticoagulant medications are at increased risk of bleeding and should be especially cautious when using this drug. Patients with cardiovascular diseases may be affected in heart function due to the included epinephrine, and their conditions should be closely monitored during use. Patients with a history of strokes should avoid using this drug for six months post-stroke due to the risk of recurrence. Patients with a history of epilepsy or plasma cholinesterase deficiency, liver or kidney disorders, elderly patients, uncontrolled diabetes, pulmonary disease, hyperthyroidism, pheochromocytoma, acute closed-angle glaucoma, those taking phenothiazines, and non-selective beta-blockers should also be administered this drug with care. This drug contains sodium metabisulfite, which can cause allergic reactions, particularly in asthma patients, leading to severe asthma attacks, so caution is required. Various adverse effects may occur with this drug, ranging from common to very rare, affecting multiple areas including the nervous system, heart, blood vessels, respiratory tract, gastrointestinal tract, and skin. In particular, neurological adverse reactions may include sensory disturbances, headache, and neuralgia, while cardiovascular effects may present as bradycardia or tachycardia, and changes in blood pressure. Before injection, the patient's allergy history and constitution, as well as recent treatment history, must be verified. It is advisable to perform a small test injection if there is a risk of allergy. During injection, the drug should be administered slowly while performing repeated aspiration checks to prevent intra-vascular injection, avoiding nerve blocks, and maintaining continuous communication with the patient to detect any abnormal symptoms. This drug may interact with other local anesthetics, sedatives, certain antidepressants, beta-blockers, and others, so caution is needed when co-administering with other drugs. During pregnancy, this drug should be used only when the benefits outbalance the risks, and similar caution is advised during breastfeeding. This drug can cause dizziness or visual disturbances, which can affect driving or operating machinery, so caution is advised after administration. In case of overdose, severe side effects can occur in the central nervous and cardiovascular systems, requiring immediate cessation of administration and appropriate emergency treatment. Before use, cartridges must be disinfected, used immediately after opening, and should not be mixed with other medications.

Side effects

Convulsions, central nervous system and cardiopulmonary depression, coma, respiratory and circulatory arrest, localized necrosis, anaphylactic reactions, allergies, anaphylaxis, anaphylactoid reactions, neurohysteria, anxiety, euphoria, neuralgia, sensory impairment, numbness, sensory hyperesthesia, sensory abnormalities, dysgeusia, loss of taste, colicky pain, hypersensitivity to temperature perception, headache, burning sensation, facial nerve disorders, Horner's syndrome, drowsiness, nystagmus, sensory abnormalities after mandibular or inferior alveolar nerve block, diplopia, visual disturbances, ptosis, miosis, enophthalmos, auditory hyperesthesia, tinnitus, bradycardia, tachycardia, palpitations, hypotension, hypertension, facial flushing, localized hyperemia, vasodilation, vasoconstriction, bronchospasm, asthma, difficulty breathing, speech disturbances, tongue swelling, lip swelling, gum swelling, stomatitis, glossitis, nausea, vomiting, diarrhea, gingival and oral mucosa desquamation, ulcers, dysphagia, cheek swelling, glossalgia, rash, itching, angioedema, urticaria, erythema, sweating, cervical pain, muscle cramping, injection site pain, injection site desquamation, necrosis, fatigue, asthenia, chills, localized swelling, warmth, sensation of cold, presyncope, syncope, headache, restlessness, confusion, disorientation, dizziness, tremors, stupor, severe CNS depression, loss of consciousness, convulsions, speech impairment, vertigo, balance disorders, mydriasis, blurred vision, accommodation disorders, pallor, apnea, slow breathing, tachypnea, yawning, respiratory depression, cardiac arrest, myocardial depression

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent air ingress. The storage temperature should be maintained between 1 degree and 25 degrees Celsius (room temperature), and it is recommended to store it in a dark place away from direct sunlight.

Appearance and packaging

Appearance

A cartridge-type ampoule filled with a colorless, transparent liquid

Package unit

1.7㎖ × 50 cartridges

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.